Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04354545 · ClinicalTrials.gov registry record
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
A clinical trial of Glaucoma and Ocular Surface Disease, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT04354545: Recruiting study of Glaucoma and Ocular Surface Disease, sponsored by University of California, Los Angeles.
NCT04354545 is a study of Glaucoma and Ocular Surface Disease that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 75 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04354545, a study of Glaucoma and Ocular Surface Disease, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Primary Outcome
Change in corneal fluorescein staining score
Conditions Studied
Interventions
- DRUG Xiidra (Lifitegrast ophthalmic solution) 5%
Study Locations (1)
California
- Doheny Eye Center UCLA - Fountain Valley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-12-01 |
What NCT04354545 shows while recruiting
NCT04354545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Xiidra (Lifitegrast ophthalmic solution) 5% is the first listed.
NCT04354545 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04354545 about?
NCT04354545 is a clinical study titled "Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications". To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
What is the current status of trial NCT04354545?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2021-04-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04354545 study?
This clinical trial studies the following conditions: Glaucoma, Ocular Surface Disease.
What interventions are being tested in trial NCT04354545?
The interventions under investigation include: Xiidra (Lifitegrast ophthalmic solution) 5% (DRUG).
Who is sponsoring clinical trial NCT04354545?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04354545 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04354545's enrollment target sits among peer trials
75 51st of 92 higher than 42 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI